Gelonghui, March 1, 丨 Jilin Aodong (000623.SZ) announced that recently, Jilin Aodong Taonan Pharmaceutical Co., Ltd. (“Taonan Pharmaceutical”), a holding subsidiary of Jilin Aodong Pharmaceutical Group Co., Ltd., received the specifications of pibesilide capsules issued by the State Drug Administration: 100 mg, 75 mg, 125 mg, and the “Notice of Approval of Application for the Marketing of Chemical Ingredients”.
吉林敖东(000623.SZ)：洮南药业获得药品注册证书及化学原料药上市申请批准通知书
Aodong, Jilin (000623.SZ): Taonan Pharmaceutical obtained a drug registration certificate and a notice of approval for the marketing application of chemical raw materials
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.